New Data Add Fuel to Paclitaxel-Device Firestorm in PAD - Medscape

New Data Add Fuel to Paclitaxel-Device Firestorm in PAD  Medscape

Industry rallied with a phalanx of new data after a controversial meta-analysis reported a higher late mortality signal with paclitaxel-coated devices.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more